Elias Chandran, MBBS, FRACP

National Cancer Institute

Latest Content

Dr. Elias Chandran and Dr. Andrea Apolo discuss the latest developments in bladder cancer care, highlighting EV-Pembrolizumab's role in redefining treatment strategies.

Conferences

06/06/2026

The Impact of EV Trials Across Bladder Cancer Populations

Andrea Apolo, MDElias Chandran, MBBS, FRACP

Efficacy of Enfortumab Vedotin and Pembrolizumab in muscle-invasive bladder cancer treatment, featuring experts Elias Chandran and Vishesh Khanna against a cityscape background.

Bladder Cancer

03/09/2026

Enfortumab Vedotin-Pembrolizumab’s Role in Muscle-Invasive Bladder Cancer Treatment

Elias Chandran, MBBS, FRACPVishesh Khanna, MD